ITP

17 registered clinical trials studyying ITP — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children NCT07214025	Assiut University	—
Recruiting	A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thro NCT07194850	argenx	Phase 2 / Phase 3
Recruiting	A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP) NCT07043946	Climb Bio, Inc.	Phase 1 / Phase 2
Unknown	IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP NCT04482777	Assiut University	—
Unknown	Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluati NCT04735588	Gruppo Italiano Malattie EMatologiche dell'Adulto	—
Unknown	Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia NCT05446831	Peking University People's Hospital	Phase 2
Completed	An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP NCT04943042	Swedish Orphan Biovitrum	—
Unknown	Gut Microbiota in ITP NCT05118126	Peking University People's Hospital	—
Unknown	Anti-BCMA CAR T-Cell Therapy for R/R ITP NCT05315778	The First Affiliated Hospital of Soochow University	Phase 2
Unknown	Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia NCT05116423	Peking University People's Hospital	—
Recruiting	Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266	Sanguine Biosciences	—
Unknown	The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopeni NCT05281068	Peking University People's Hospital	Phase 2
Terminated	Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP NCT04904276	Rigel Pharmaceuticals	—
Unknown	The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytop NCT04747080	Peking University People's Hospital	Phase 2
Unknown	The DART Study- Daratumumab Treatment in ITP NCT04703621	Ostfold Hospital Trust	Phase 2
Completed	Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Pati NCT04089267	Shenyang Sunshine Pharmaceutical Co., LTD.	Phase 4
Completed	Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone NCT02914054	Isfahan University of Medical Sciences	Phase 2 / Phase 3